Two Genes Play Crucial Role In Breast Cancer - Blocking Genes Prevent Metastasis

Main Category: Breast Cancer
Also Included In: Genetics;  Cancer / Oncology
Article Date: 15 Feb 2009 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Scientists from Weill Cornell Medical College have discovered the role of two recently identified genes in promoting breast cancer metastasis. They believe their findings are important for patients, who die more often from late-stage cancer that spreads to other organs and tissues, than from their primary breast tumor.

The findings, published in the Feb. 2 issue of Cancer Cell, show that cancer cell migration and metastasis was halted after blocking the function of the two genes, called Ora1 and STIM1. When their function is not blocked, these genes allow calcium to enter into the cell, which amplifies cell locomotion, replication and growth.

To make their findings, Dr. Xin-Yun Huang, senior author and a professor of physiology and biophysics, and Dr. Shengyu Yang, the study's first author, experimented on samples of human breast tissues removed from metastatic cancer tumors. In laboratory experiments, they found that blocking the two genes prevented cell migration. The same cancer cells were then labeled with fluorescent markers, in order to track the cells within the body, and injected into fatty tissues of mice that resemble human breast tissues. The investigators found that the spreading of these cells was stopped within mice whose Ora1 and STIM1 genes were blocked, just as found in the laboratory experiments.

These findings are very exciting because the authors consider them to constitute a big step toward creating a therapeutic agent that would block the function of these genes and thus prevent or slow breast cancer metastasis in humans. Dr. Huang adds that preliminary data show that within metastatic breast cancer tissues there is also a higher expression of these two genes, reinforcing the view of their roles and of their usefulness as therapeutic targets.

Weill Cornell Science Briefs

Weill Cornell Science Briefs is an electronic newsletter published by the Office of Public Affairs that focuses on innovative medical research and patient care at Weill Cornell Medical College and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The newsletter is sent electronically to journalists and available to all on this Web site. To read Science Briefs on the Web, please visit: http://med.cornell.edu/science.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center

NewYork-Presbyterian Hospital/Weill Cornell Medical Center, located in New York City, is one of the leading academic medical centers in the world, comprising the teaching hospital NewYork-Presbyterian and Weill Cornell Medical College, the medical school of Cornell University. NewYork-Presbyterian/Weill Cornell provides state-of-the-art inpatient, ambulatory and preventive care in all areas of medicine, and is committed to excellence in patient care, education, research and community service. Weill Cornell physician-scientists have been responsible for many medical advances -- from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial for gene therapy for Parkinson's disease, the first indication of bone marrow's critical role in tumor growth, and, most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. NewYork-Presbyterian, which is ranked sixth on the U.S.News & World Report list of top hospitals, also comprises NewYork-Presbyterian Hospital/Columbia University Medical Center, Morgan Stanley Children's Hospital of NewYork-Presbyterian, NewYork-Presbyterian Hospital/Westchester Division and NewYork-Presbyterian Hospital/The Allen Pavilion. Weill Cornell Medical College is the first U.S. medical college to offer a medical degree oversees and maintains a strong global presence in Austria, Brazil, Haiti, Tanzania, Turkey and Qatar. For more information, visit http://www.nyp.org and http://www.med.cornell.edu.

NewYork-Presbyterian Hospital
Weill Cornell Medical Center